Visceral Hypersensitivity means the internal organs feel pain or discomfort more easily than expected. It describes heightened sensing from the gastrointestinal (GI) tract or other abdominal organs. It is commonly discussed in functional GI disorders, such as irritable bowel syndrome (IBS). Clinicians also use it to interpret symptoms when tests do not show clear structural disease.
Leaky Gut is a nontechnical term that usually refers to increased intestinal permeability. It describes a situation where the gut lining allows more substances to pass from the intestinal lumen into the body than expected. The phrase is common in popular health discussions and also appears in research contexts. In clinical practice, clinicians more often use precise terms like “intestinal barrier dysfunction” rather than Leaky Gut.
Intestinal Permeability describes how easily substances pass from the gut lumen into the body across the intestinal lining. It is a normal physiologic property that supports nutrient and water absorption while limiting harmful exposures. In clinical medicine, the term is commonly used when discussing barrier function, inflammation, infection, and certain GI disorders. It may also refer to how permeability is *measured* in research or selected clinical settings.
The Gut Barrier is the body’s multi-layer system that separates the intestinal lumen from the internal bloodstream and tissues. It allows nutrient and water absorption while limiting entry of pathogens and toxins. It is discussed in gastroenterology, hepatology, critical care, and nutrition science. Clinicians reference it when thinking about inflammation, infection risk, and intestinal permeability.
Gut Flora is the community of microorganisms that live in the gastrointestinal (GI) tract. It mainly refers to bacteria, but also includes viruses, fungi, and archaea. The term is commonly used in gastroenterology to describe how microbes interact with digestion and immunity. It is also used in clinical discussions about infections, inflammation, and “microbiome” testing.
The Microbiome is the community of microbes that live on and inside the human body. It includes bacteria, viruses, fungi, and other microorganisms, plus their genes and byproducts. In gastroenterology, the term most often refers to the gut Microbiome in the intestines. It is commonly used in clinical research and increasingly in patient-centered discussions of digestive health.
Fecal Transplant is a therapy that transfers processed stool from a screened donor into a patient’s gastrointestinal tract. It aims to restore a healthier community of gut microbes (the intestinal microbiome). It is most commonly discussed in the care of recurrent *Clostridioides difficile* infection (often abbreviated *C. difficile* or CDI). It is performed in specialized clinical settings using standardized screening and delivery methods.
Gallbladder Cancer is a malignant (cancerous) growth that arises in the gallbladder. The gallbladder is a small organ under the liver that stores and concentrates bile. Gallbladder Cancer is commonly discussed in hepatobiliary surgery, gastroenterology, oncology, and radiology. It is often identified during evaluation of biliary symptoms or incidentally after gallbladder removal.
Pancreatic Adenocarcinoma is a malignant (cancerous) tumor that arises from gland-forming cells in the pancreas. It most often refers to pancreatic ductal adenocarcinoma, which develops from cells lining pancreatic ducts. In clinical care, it is commonly discussed in the setting of unexplained jaundice, weight loss, abdominal pain, or a pancreatic mass on imaging. It is a central diagnosis in gastroenterology, hepatobiliary medicine, oncology, and gastrointestinal (GI) surgery.
Cholangiocarcinoma is a malignant (cancerous) tumor that arises from the bile duct epithelium (the lining cells of bile ducts). It is discussed in gastroenterology, hepatology, and GI surgery because bile ducts are part of the hepatobiliary system (liver and bile drainage). In clinical practice, the term is used when evaluating bile duct strictures, jaundice, or liver masses that may represent bile duct cancer. It is commonly classified by where it starts: inside the liver, at the liver hilum, or in the extrahepatic (outside the liver) bile duct.